Research Paper Volume 12, Issue 4 pp 3312—3339

Analysis of immune-related signatures of lung adenocarcinoma identified two distinct subtypes: implications for immune checkpoint blockade therapy

Figure 3. Distribution of TIDE scores in high-risk subtype of LUAD versus low-risk subtype of LUAD. (A) Boxplot representation of TIDE scores in the high-risk group versus low-risk group in TCGA LUAD cohort. (B) Forest plot representation of multivariate model with adjustment for confounding factors in TCGA cohort. (C) Distribution of TIDE scores in 9 independent validation cohorts.